4//SEC Filing
COYLE MICHAEL J 4
Accession 0001127602-19-033063
CIK 0001613103other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 5:31 PM ET
Size
14.6 KB
Accession
0001127602-19-033063
Insider Transaction Report
Form 4
COYLE MICHAEL J
EVP & Group Pres,Cardiac& Vasc
Transactions
- Exercise/Conversion
Ordinary Shares
2019-11-15$38.81/sh+36,874$1,431,080→ 225,136 total - Sale
Ordinary Shares
2019-11-15$111.31/sh−25,710$2,861,883→ 192,059 total - Sale
Ordinary Shares
2019-11-15$112.07/sh−3,797$425,530→ 188,262 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-15−36,874→ 0 totalExercise: $38.81Exp: 2022-07-30→ Ordinary Shares (36,874 underlying) - Sale
Ordinary Shares
2019-11-15$110.58/sh−7,367$814,680→ 217,769 total
Holdings
- 250(indirect: By Trust)
Ordinary Shares
- 4,104(indirect: By Spouse)
Ordinary Shares
Footnotes (5)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.96 to $110.96, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.96 to $111.88, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.98 to $112.15, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
- [F5]This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
Documents
Issuer
Medtronic plc
CIK 0001613103
Entity typeother
Related Parties
1- filerCIK 0001233311
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 5:31 PM ET
- Size
- 14.6 KB